New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential

Colorectal cancer (CRC) is among the most deadly cancers worldwide. Current therapeutic strategies have low success rates and several side effects. This relevant clinical problem requires the discovery of new and more effective therapeutic alternatives. Ruthenium drugs have arisen as one of the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Brás, Ana Rita, Fernandes, Pedro, Moreira, Tiago, Morales-Sanfrutos, Julia, Sabidó, Eduard, Antunes, Alexandra M. M., Valente, Andreia, Preto, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302444/
https://www.ncbi.nlm.nih.gov/pubmed/37376178
http://dx.doi.org/10.3390/pharmaceutics15061731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302444/
https://www.ncbi.nlm.nih.gov/pubmed/37376178
http://dx.doi.org/10.3390/pharmaceutics15061731

Ejemplares similares